Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2866793/13009/en/Catalyst-Pharmaceuticals-to-Report-First-Quarter-2024-Financial-Results-on-May-8-2024.html
https://www.globenewswire.com/news-release/2024/03/28/2853962/13009/en/Catalyst-Pharmaceuticals-Announces-Support-for-the-Inaugural-Lambert-Eaton-Myasthenic-Syndrome-LEMS-Awareness-Day.html
https://www.globenewswire.com/news-release/2024/03/27/2853130/13009/en/Catalyst-Pharmaceuticals-to-Participate-in-the-2024-Cantor-Virtual-Muscular-Dystrophy-Symposium.html
https://www.globenewswire.com//news-release/2024/03/14/2845975/0/en/Santhera-s-Partner-Catalyst-Pharmaceuticals-Launches-AGAMREE-Vamorolone-in-the-United-States.html
https://www.globenewswire.com//news-release/2024/03/13/2845339/13009/en/Catalyst-Pharmaceuticals-Announces-AGAMREE-Now-Commercially-Available-in-the-U-S-for-the-Treatment-of-Duchenne-Muscular-Dystrophy-DMD.html
https://www.globenewswire.com//news-release/2024/03/05/2840420/13009/en/Catalyst-Pharmaceuticals-to-Participate-at-the-Barclays-26th-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/28/2837533/13009/en/Catalyst-Pharmaceuticals-Reports-Strong-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/27/2835996/13009/en/Catalyst-Pharmaceuticals-to-Present-at-MDA-Clinical-Scientific-Conference-Details-of-Registry-for-Study-of-Long-Term-Safety-and-Quality-of-Life-in-Duchenne-Muscular-Dystrophy-Patie.html
https://www.globenewswire.com//news-release/2024/02/21/2832813/13009/en/Catalyst-Pharmaceuticals-Announces-Publication-of-Santhera-Pharmaceutical-s-VISION-DMD-Vamorolone-AGAMREE-Study-Results-in-the-Peer-Reviewed-Journal-Neurology.html
https://www.globenewswire.com//news-release/2024/02/14/2829058/13009/en/Catalyst-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-28-2024.html